Hereditary Angioedema Market Size 2023: Analysis of Epidemiology, Industry Trends, Share, and Future Forecast by 2033

The newly published report by IMARC Group, titled, ”Hereditary Angioedema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2033″, presents a comprehensive assessment of the hereditary angioedema market size. The report provides an overview of the market trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease overview, market scenario, and growth trends.

Hereditary angioedema, also called HAE, represents a rare genetic disorder that is caused by dysfunctional or lack of C1-inhibitor protein. This condition is generally inherited in an autosomal dominant pattern, which implies one copy of the altered gene in each cell. Hereditary angioedema is usually characterized by severe, subcutaneous, and submucosal swelling of the hands, face, airways, intestinal tract, trachea, larynx, or tongue. It affects the blood vessels and leads to nausea, vomiting, extreme pain, fatigue, diarrhea, muscle ache, tingling, headache, abdominal pain, hoarseness, mood swings, etc. Hereditary angioedema also leads to the constant accumulation of liquids.

Request a Free Sample Report: https://www.imarcgroup.com/hereditary-angioedema-market/requestsample

Market Trend:

The growing prevalence of genetic mutations is primarily driving the hereditary angioedema market. Additionally, the launch of various favorable policies by government bodies across countries for developing modern, safe, and effective drugs to treat disease and providing preventive medical care is further catalyzing the market growth. Besides this, easy accessibility of advanced diagnostic tools and medications, the inflating need for facilitating faster diagnosis, and the rising awareness among patients towards the treatment of hereditary angioedema are acting as significant growth-inducing factors.

Moreover, the widespread adoption of hereditary angioedema therapeutics, the expanding healthcare industry, and extensive R&D activities are positively influencing the global market. Apart from this, the escalating demand for enhanced procedures that are highly effective in administering medications is also stimulating the market growth. Furthermore, the introduction of novel drugs, including diacetylmorphine and goserelin, to treat this disorder is expected to fuel the hereditary angioedema market over the forecasted period.

Report Period:

Base Year: 2022

Historical Period: 2017-2022

Market Forecast: 2023-2033

Countries Included:

United States

Germany

France

United Kingdom

Italy

Spain

Japan

Analysis Covered Across Each Country

Historical, current, and future epidemiology scenario

Historical, current, and future performance of the hereditary angioedema market

Historical, current, and future performance of various therapeutic categories in the market

Sales of various drugs across the hereditary angioedema market

Reimbursement scenario in the market

In-market and pipeline drugs

In-Market Drugs

Drug Overview

Mechanism of Action

Regulatory Status

Clinical Trial Results

Drug Uptake and Market Performance

Late-Stage Pipeline Drugs

Drug Overview

Mechanism of Action

Regulatory Status

Clinical Trial Results

Regulatory Status

Ask an Analyst for Report Customization with TOC & List of figures: https://www.imarcgroup.com/hereditary-angioedema-market

Key Questions Answered in this Report:

How has the hereditary angioedema market performed so far and how will it perform in the coming years?

What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?

What was the country-wise size of the hereditary angioedema market across the seven major markets in 2022 and what will it look like in 2033?

What is the growth rate of the hereditary angioedema market across the seven major markets and what will be the expected growth over the next ten years?

What are the key unmet needs in the market?

About Us: –

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St.

Brooklyn, NY 11249, USA

Email: [email protected]

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800